Xing Zhang

机构：Shandong University of Technology, Chinese Academy of Sciences, Yinchuan First People's Hospital, Simcere Pharmaceutical (China), Shanghai Ninth People's Hospital, Institute of Physics, National Laboratory for Superconductivity, Hangzhou Medical College · ORCID：0000-0001-8542-8353

发表论文 204 篇 · 总被引 5067 次 · h-index 33

代表论文

• Surface functionalization of exosomes for chondrocyte-targeted siRNA delivery and cartilage regeneration (2024 · Journal of Controlled Release · 被引 81)
• Reversing Immune Checkpoint Inhibitor–Associated Cardiotoxicity via Bioorthogonal Metabolic Engineering–Driven Extracellular Vesicle Redirecting (2024 · Advanced Materials · 被引 19)
• Realization of Kagome Kondo lattice (2025 · Nature Communications · 被引 12)
• FOXO1 Integrates Endothelial Hemodynamic, Inflammatory, and Metabolic Pathways in Atherosclerosis (2026 · Circulation Research · 被引 10)
• Netrin1‐Enriched Exosomes From Genetically Modified ADSCs as a Novel Treatment for Diabetic Limb Ischemia (2024 · Advanced Healthcare Materials · 被引 10)
• First-in-human phase I study of BEBT-109 in previously treated EGFR exon 20 insertion-mutated advanced non-small cell lung cancer (2024 · Med · 被引 9)